LLibera Bio — Seed · approximately €1.59M
XesGalicia, through its Galicia InnovaTech fund, invested €289,500 in a capital increase at Libera Bio, a University of Santiago de Compostela spin-off developing nanoparticle-delivered antibody therapies for cancer (MPN Technology). The total size of the round was not disclosed at announcement; XesGalicia joined alongside family office Rosp Corunna Participaciones Empresariales and a private investor, following venture builder Nowture's earlier entry.
Lead not disclosed
RoundSeed
Announced24 Jan 2022
CitySantiago de Compostela
SectorHealthtech & Bio · Biotech
Source
W
W
Extended 4 Jul 2022: +€1.3M from Iñaki Berenguer, Nowture, Semola Tech Ventures and 1 more
The company
Investors 6
I
Iñaki Berenguer
On the team at Zubi Capital → +3: also iPronics, MITO, InfiniteWatch
M
Manuel Francisco Rañal Loureiro
N
Nowture
R
Rosp Corunna Participaciones Empresariales
S
Semola Tech Ventures
XXesGalicia (Galicia InnovaTech)
www.xesgalicia.org